{
    "nct_id": "NCT06101069",
    "official_title": "Development of Magnetic Resonance Fingerprinting for Characterization of Brain Tumors After Radiotherapy",
    "inclusion_criteria": "Healthy volunteers allowed\nMust have minimum age of 21 Years\nMust have maximum age of 60 Years",
    "exclusion_criteria": "* Pregnant women OR lactating women\n* Participants with ferromagnetic or otherwise non-MRI compatible aneurysm clips.\n* Participants who cannot go into the MRI scanner due to metal implants and other medical conditions.\n* The presence of an implanted medical device that is not MRI-compatible, including, but not limited to: pacemaker, defibrillator.\n* Participants with contraindications for MRI due to embedded foreign metallic objects such as bullets, shrapnel, metalwork fragments, or other metallic material.\n* Known history of severe claustrophobia.\n* Participants unable to lay still in the scanner for 30 minutes at a time.",
    "miscellaneous_criteria": "Inclusion Criteria for Healthy Participants:\n\n* No history of cerebrovascular disease.\n* No cognitive impairments.\n* Able to provide informed consent.\n\nInclusion Criteria for Participants with Brain Tumors:\n\n* Biopsy-proven cases of developed recurrent tumor or radiation necrosis,\n\nOR:\n\n* a. PET identified with developed recurrent tumor or radiation necrosis. OR\n* b. Highly suspicious case with developed recurrent tumor or radiation necrosis confirmed by tumor board, attending physician or surgeon.\n* ECOG performance status 0-2.\n* Life expectancy > 6 months.\n* Participant with other sites of extracranial metastatic disease or any prior or current systemic therapies will be considered and evaluated by the investigators of the study on a subject basis."
}